Julian Dorey Podcast

#376 - “Disaster!” - Cartel-Tracked CEO on (Legal) Drug 13x More Potent than MORPHINE | Ryan Niddel

Jan 23, 2026
Ryan Niddel, CEO of Diversified Botanics and kratom industry safety advocate, discusses kratom origins and the 7‑OH potency problem. He covers regulatory fights with FDA/DEA, tech fixes like blockchain and AI for traceability, transparency measures like QR/COA systems, and links between suppliers, cartels, and market pressures driving a potency arms race.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Isolation Amplifies Potency Risks

  • Isolating alkaloids changes safety and potency dramatically versus whole-leaf kratom.
  • 7-hydroxymitragynine (7-OH) can be far more potent than mitragynine and behaves very differently.
ANECDOTE

Customers Addicted To 7-OH Tell Their Stories

  • Customers reported buying 7-OH at stores and then becoming quickly dependent, prompting outreach to the company.
  • One man required outpatient rehab and was placed on Suboxone after using 7-OH.
INSIGHT

Toxicology Reveals Confounding Factors

  • Toxicology from a wrongful-death suit showed kratom plus very high amphetamine levels, complicating causation.
  • Co-consumed substances can confound blame on kratom alone.
Get the Snipd Podcast app to discover more snips from this episode
Get the app